Article Details

Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti ...

Retrieved on: 2024-07-20 14:34:21

Tags for this article:

Click the tags to see associated articles and topics

Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti .... View article details on hiswai:

Summary

The article outlines a clinical trial investigating broadly neutralizing HIV-1 antibodies (bNAbs) to prevent mother-to-child HIV transmission during the breastfeeding period. Participants, including pregnant and post-delivery women, will receive informed consent before participation, addressing both the management of HIV/AIDS and implications during pregnancy.

Article found on: bmcinfectdis.biomedcentral.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up